Eton Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Eton Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2020 to Q2 2024.
  • Eton Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 25.8M shares, a 0.72% increase year-over-year.
  • Eton Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 25.6M shares, a 1.99% increase from 2022.
  • Eton Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 25.1M shares, a 0.25% decline from 2021.
  • Eton Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 25.2M shares, a 20% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 25.8M +185K +0.72% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 25.8M +238K +0.93% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 25.6M +500K +1.99% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 25.7M +354K +1.4% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 25.6M +467K +1.86% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 25.5M +224K +0.89% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 25.1M -61.6K -0.25% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 25.4M +89K +0.35% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 25.1M -85K -0.34% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 25.3M +848K +3.47% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 25.2M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 25.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 25.2M +4.21M +20% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 24.5M +6.31M +34.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q2 2020 21M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 18.1M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.